Clinical Trials Browser

Phase 2 × prexasertib × 1 year × Clear all

NCT05548296 2026-01-22

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Phase 2 Recruiting

Endometrial Neoplasms

NCT06597565 2025-10-20

A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck